#egfrmutations

Non-small cell lung cancer is a slower-growing variant that can be managed through various approaches, such as radiation therapy, surgery, chemotherapy, and targeted therapy. The tyrosine kinase inhibitors (TKIs) resistance of the epidermal growth factor receptor (EGFR) in advanced mutant non-small cell lung cancer (NSCLC) has a therapeutic challenge. #mrmed #mrmedpharmacy #egfrmutations #lungcancer #nsclc #tagrisso80 Know more: https://mrmedin.mystrikingly.com/blog/challenges-and-opportunities-in-overcoming-egfr-tki-resistance-in-nsclc

The non-small cell lung cancer (NSCLC) is the most prevalent and challenging kind of cancer in the world. The prevalence of EGFR (Epidermal Growth Factor Receptor) mutations in NSCLC has become an important factor in both diagnosis and therapy. The EGFR protein, sometimes referred to as the epidermal growth factor receptor, is crucial for regulating cell division and development. #mrmed #mrmedpharmacy #egfrmutations #nonsmallcell #lungcancer #gefitinib Know more: https://www.zupyak.com/p/3866810/t/overview-of-egfr-mutations-in-non-small-cell-lung-cancer